Peter Madsen,Thomas Hoeg-Jensen,Thomas Børglum Kjeldsen,Tina Møller Tagmose
申请号：
US13306411
公开号：
US20120071402A1
申请日:
2011.11.29
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Novel PEGylated insulin analogues exhibiting resistance towards proteases can, effectively, be administered pulmonary or orally. The insulin analogues contain B25H and A14E or A14H. The PEGylation is at B29K.
